As of December 2024 Immunome has a market cap of $0.75 Billion USD. This makes Immunome the world's 6056th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 17th, 2024 the market cap of Immunome was reported to be: